Irina V Klimanskaya

This inventor holds 25 USPTO granted patents and 18 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Retinal Cell Therapy. Top assignees: Astellas Institute for Regenerative Medicine, Advanced Cell Technology, Inc., Ocata Therapeutics, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irina V Klimanskaya. Retrieved from https://idiyas.com/inventor/irina-v-klimanskaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 18)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 19)

Average Co-Inventor Count = 2.3

ph-index = 13

Forward Citations = 366(Granted Patents)

Company Filing History:

10 out of 40

Astellas Institute for Regenerative Medicine

patents

8 out of 21

Advanced Cell Technology, Inc.

patents

7 out of 10

Ocata Therapeutics, Inc.

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Retinal Degeneration

Stem Cell Derivation

Cell Detection

Human Retinal Pigment Epithelium

Ex Vivo Development

Photoreceptor Progenitors

Cell Assays

Enriched Populations

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545945 - Methods for detection of rare subpopulations of cells and highly purified composition of cells (2026-02-10),

2. 11739366 - Methods for detection of rare subpopulations of cells and highly purified compositions of cells (2023-08-29),

3. 11680941 - Assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors (2023-06-20),

4. 11422125 - Assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors (2022-08-23),

5. 10072243 - Derivation of embryonic stem cells and embryo-derived cells (2018-09-11),

6. 9730962 - Modalities for the treatment of degenerative diseases of the retina (2017-08-15),

7. 9650607 - Modalities for the treatment of degenerative diseases of the retina (2017-05-16),

8. 9649340 - Methods for producing enriched populations of human retinal pigment epithelium cells (2017-05-16),

9. 9617512 - Derivation of embryonic stem cells and embryo-derived cells (2017-04-11),

10. 9562217 - Modalities for the treatment of degenerative diseases of the retina (2017-02-07),

11. 9193950 - Modalities for the treatment of degenerative diseases of the retina (2015-11-24),

12. 9181524 - Modalities for the treatment of degenerative diseases of the retina (2015-11-10),

13. 9080150 - Modalities for the treatment of degenerative diseases of the retina (2015-07-14),

14. 9045732 - Modalities for the treatment of degenerative diseases of the retina (2015-06-02),

15. 9040770 - Modalities for the treatment of degenerative diseases of the retina (2015-05-26),

Title: Inventor Irina V Klimanskaya

Introduction: Irina V Klimanskaya is a notable inventor based in Upton, MA (US) known for her groundbreaking contributions to the field of biotechnology.

Latest Patents: Irina V Klimanskaya holds several patents related to stem cell research and regenerative medicine, focusing on innovative techniques for cell reprogramming and differentiation.

Career Highlights: With a background in molecular biology, Irina V Klimanskaya has had a successful career working in various research institutions and biotech companies, where she has spearheaded projects that have pushed the boundaries of scientific knowledge.

Collaborations: Throughout her career, Irina V Klimanskaya has collaborated with leading scientists and researchers in the field, fostering a culture of innovation and knowledge-sharing that has led to significant advancements in biotechnology.

Conclusion: Irina V Klimanskaya's dedication to scientific discovery and her pioneering work in stem cell research continue to inspire the next generation of inventors and researchers in the field of biotechnology.

Profile summary based on public USPTO records.